Meyka Pro banner
Aehr Test Systems

Aehr Test Systems Fundamental Analysis (NASDAQ: AEHR)

AEHR●NASDAQ
TechnologySemiconductors
$65.78
$6.21(10.42%)
U.S. Market opens in 1h 51m

Aehr Test Systems Fundamental Analysis (NASDAQ: AEHR)

Aehr Test Systems (NASDAQ: AEHR) shows weak financial fundamentals with a PE ratio of 1092.95, profit margin of 2.93%, and ROE of 1.20%. The company generates $0.1B in annual revenue with weak year-over-year growth of -10.95%.

Key Strengths

Current Ratio7.15

Areas of Concern

ROE1.20%
Operating Margin-5.54%
Cash Position4.89%
PEG Ratio23.23
We analyze AEHR's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 21.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
21.7/100

We analyze AEHR's fundamental strength across five key dimensions:

Efficiency Score

Weak

AEHR struggles to generate sufficient returns from assets.

ROA > 10%
0.83%

Valuation Score

Weak

AEHR trades at a premium to fair value.

PE < 25
1092.95
PEG Ratio < 2
23.23

Growth Score

Weak

AEHR faces weak or negative growth trends.

Revenue Growth > 5%
-10.95%
EPS Growth > 10%
-1.11%

Financial Health Score

Excellent

AEHR maintains a strong and stable balance sheet.

Debt/Equity < 1
0.04
Current Ratio > 1
7.15

Profitability Score

Weak

AEHR struggles to sustain strong margins.

ROE > 15%
120.31%
Net Margin ≥ 15%
2.93%
Positive Free Cash Flow
No

Key Financial Metrics

Is AEHR Expensive or Cheap?

P/E Ratio

AEHR trades at 1092.95 times earnings. This suggests a premium valuation.

1092.95

PEG Ratio

When adjusting for growth, AEHR's PEG of 23.23 indicates potential overvaluation.

23.23

Price to Book

The market values Aehr Test Systems at 9.57 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

9.57

EV/EBITDA

Enterprise value stands at 944.65 times EBITDA. This signals the market has high growth expectations.

944.65

How Well Does AEHR Make Money?

Net Profit Margin

For every $100 in sales, Aehr Test Systems keeps $2.93 as profit after all expenses.

2.93%

Operating Margin

Core operations generate -5.54 in profit for every $100 in revenue, before interest and taxes.

-5.54%

ROE

Management delivers $1.20 in profit for every $100 of shareholder equity.

1.20%

ROA

Aehr Test Systems generates $0.83 in profit for every $100 in assets, demonstrating efficient asset deployment.

0.83%

Following the Money - Real Cash Generation

Operating Cash Flow

Aehr Test Systems generates limited operating cash flow of $-6.09M, signaling weaker underlying cash strength.

$-6.09M

Free Cash Flow

Aehr Test Systems generates weak or negative free cash flow of $-6.82M, restricting financial flexibility.

$-6.82M

FCF Per Share

Each share generates $-0.21 in free cash annually.

$-0.21

FCF Yield

AEHR converts -0.32% of its market value into free cash.

-0.32%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

1092.95

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

23.23

vs 25 benchmark

P/B Ratio

Price to book value ratio

9.57

vs 25 benchmark

P/S Ratio

Price to sales ratio

29.16

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.04

vs 25 benchmark

Current Ratio

Current assets to current liabilities

7.15

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.01

vs 25 benchmark

ROA

Return on assets percentage

0.008

vs 25 benchmark

ROCE

Return on capital employed

-0.02

vs 25 benchmark

How AEHR Stacks Against Its Sector Peers

MetricAEHR ValueSector AveragePerformance
P/E Ratio1092.9532.70 Worse (Expensive)
ROE1.20%758.00% Weak
Net Margin2.93%-4312.00% (disorted) Weak
Debt/Equity0.040.96 Strong (Low Leverage)
Current Ratio7.1512.15 Strong Liquidity
ROA0.83%1067467.00% Weak

AEHR outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Aehr Test Systems's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

104.63%

Industry Style: Growth, Innovation, High Beta

High Growth

EPS CAGR

-7.94%

Industry Style: Growth, Innovation, High Beta

Declining

FCF CAGR

-182.81%

Industry Style: Growth, Innovation, High Beta

Declining

Fundamental Analysis FAQ